Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Yung

Showing results (121-130 of 217) with videos related to

Pageof 22
Sort By:
Annals of Neurology|January 2, 2003
Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesisCandelaria Gomez-Manzano, Juan Fueyo, Hong Jiang, et al.
Oncotarget|April 21, 2017
Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant gliomaDimpy Koul, Shuzhen Wang, Shaofang Wu, et al.
Journal of Neuro-Oncology|January 12, 2011
Age as an independent prognostic factor in patients with glioblastoma: a Radiation Therapy Oncology Group and American College of Surgeons National Cancer Data Base comparisonMalika L Siker, Meihua Wang, Kimberly Porter, et al.
Stem Cells (Dayton, Ohio)|September 17, 2013
A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cellsNorihiko Saito, Jun Fu, Siyuan Zheng, et al.
Neuro-Oncology|March 28, 2002
A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium StudyH Ian Robins, Susan M Chang, Michael D Prados, et al.
Cancer Research|August 17, 2019
Tie2-FGFR1 Interaction Induces Adaptive PI3K Inhibitor Resistance by Upregulating Aurora A/PLK1/CDK1 Signaling in GlioblastomaXiaolong Li, Emmanuel Martinez-Ledesma, Chen Zhang, et al.
Journal of Neuro-Oncology|January 18, 2012
Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathwayKe Sai, Shuzhen Wang, Veerakumar Balasubramaniyan, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2019
Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer CenterRebecca A Harrison, Mark D Anderson, David Cachia, et al.
Plos One|December 31, 2008
Exploratory analysis of the copy number alterations in glioblastoma multiformePablo Freire, Marco Vilela, Helena Deus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2011
Antitumor activity of NVP-BKM120--a selective pan class I PI3 kinase inhibitor showed differential forms of cell death based on p53 status of glioma cellsDimpy Koul, Jun Fu, Ruijun Shen, et al.
Pageof 22

Showing results (121-130 of 217) with videos related to

Sort By:
Pageof 22
Annals of Neurology|January 2, 2003
Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesisCandelaria Gomez-Manzano, Juan Fueyo, Hong Jiang, et al.
Oncotarget|April 21, 2017
Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant gliomaDimpy Koul, Shuzhen Wang, Shaofang Wu, et al.
Journal of Neuro-Oncology|January 12, 2011
Age as an independent prognostic factor in patients with glioblastoma: a Radiation Therapy Oncology Group and American College of Surgeons National Cancer Data Base comparisonMalika L Siker, Meihua Wang, Kimberly Porter, et al.
Stem Cells (Dayton, Ohio)|September 17, 2013
A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cellsNorihiko Saito, Jun Fu, Siyuan Zheng, et al.
Neuro-Oncology|March 28, 2002
A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium StudyH Ian Robins, Susan M Chang, Michael D Prados, et al.
Cancer Research|August 17, 2019
Tie2-FGFR1 Interaction Induces Adaptive PI3K Inhibitor Resistance by Upregulating Aurora A/PLK1/CDK1 Signaling in GlioblastomaXiaolong Li, Emmanuel Martinez-Ledesma, Chen Zhang, et al.
Journal of Neuro-Oncology|January 18, 2012
Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathwayKe Sai, Shuzhen Wang, Veerakumar Balasubramaniyan, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2019
Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer CenterRebecca A Harrison, Mark D Anderson, David Cachia, et al.
Plos One|December 31, 2008
Exploratory analysis of the copy number alterations in glioblastoma multiformePablo Freire, Marco Vilela, Helena Deus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2011
Antitumor activity of NVP-BKM120--a selective pan class I PI3 kinase inhibitor showed differential forms of cell death based on p53 status of glioma cellsDimpy Koul, Jun Fu, Ruijun Shen, et al.
Pageof 22